The CataloniaBio & HealthTech board met with Director General for Industry Matilde Vilarroya this week, after learning of her interest in the needs and concerns of companies in the healthcare and biomedicine sector in Catalonia in order to continue improving international competitiveness.

The board was represented by CataloniaBioHT President and CEO of Specipig Jaume Amat, First Vice-president of CataloniaBioHT and CEO of Neos Surgery Lluís Chico, and Secretary General Melqui Calzado.

Also at the meeting were Director of Competitive Strategy for the Directorate General for Industry Alberto Pezzi and Head of Strategic Analysis Miquel Hernández.

Catalonia is one of the world's leading regions in biomedicine and healthcare, with a consolidated, innovative business fabric (7.2% of the GDP and over €106 million in investment in 2018). Currently, CataloniaBioHT has more than 170 member companies and collaborating agents, such as hospitals, research centres and leading universities in R&D.

Related news:

• CataloniaBioHT takes part in creation of advisory council for National Pact for the Knowledge Society
• CataloniaBioHT participates in the commission of presidents of clusters in Catalonia
• “Busquem la fòrmula de l'èxit”, article by Jaume Amat in La Vanguardia